A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTRΔf508

Molecular Medicine

Volumn 8, Issue 2, 2002, Pages 75-87

  DeCarvalho, Ana C V ^a   Ndi, Chi P ^a   Tsopmo, Apollinaire ^a   Tane, Pierre ^a   Ayafor, Johnson ^a   Connolly, Joseph D ^a   Teem, John L ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GENISTEIN; LIMONOID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL MEMBRANE PERMEABILITY; CHLORIDE CONDUCTANCE; CHLORIDE CURRENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DIMERIZATION; DRUG PURIFICATION; DRUG SCREENING; EPITHELIUM CELL; FUNGAL STRAIN; MOLECULAR INTERACTION; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TWO HYBRID SYSTEM; YEAST;

EID: 0036051171     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402077     Document Type: Article

References (65)

1. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
2. Identification of the cystic fibrosis gene: Chromosome walking and jumping
3. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
4. Structure and function of the CFTR chloride channel
5. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans
6. ABC transporters: From microorganisms to man
7. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing
8. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP
9. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
10. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator
11. Degradation of CFTR by the ubiquitin-proteasome pathway
12. Delta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines
13. Genistein potentiates wild-type and delta F508-CFTR channel activity
14. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation
15. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
16. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein
17. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
18. Molecular pharmacology of the CFTR Cl- channel
19. Pharmacology of CFTR chloride channel activity
20. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
21. Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR
22. MalK forms a dimer independent of its assembly into the MalFGK2 ATP-binding cassette transporter of Escherichia coli
23. Purification and characterization of HisP, the ATP-binding subunit of a traffic ATPase (ABC transporter), the histidine permease of Salmonella typhimurium. Solubility, dimerization, and ATPase activity
24. In vitro disassembly and reassembly of an ABC transporter, the histidine permease
25. Crystal structure of the ATP-binding subunit of an ABC transporter
26. Pairing of the nucleotide binding domains of the transporter associated with antigen processing
27. Constituents of Trichilia hispida (Meliaceae). 3. Structures of the cytotoxic limonoids: Hispidins A, B, C
28. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium
29. A novel genetic system to detect protein-protein interactions
30. Drug discovery and development
31. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells
32. 8-Cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator
33. Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms
34. Activation of wild-type and deltaF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms
35. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels
36. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR
37. Biosynthesis and degradation of CFTR
38. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells
39. The Delta F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells
40. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments
41. The crystal structure of the MJO796 ATP-binding cassette. Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter
42. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily
43. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters
44. Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro
45. Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy
46. A monomer is the minimum functional unit required for channel and ATPase activity of the cystic fibrosis transmembrane conductance regulator
47. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity
48. Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator)
49. The multidrug resistance p-glycoprotein, Oligomeric state and intramolecular interactions
50. A limonoid from Trichilia estipulata
51. Tetranortriterpenoids and related compounds. Part 23. Complex tetranortriterpenoids from Trichilia prieuriana and Guarea thompsonii (Meliaceae), and the hydrolysis products of drageanin, prieurianin, and related compounds
52. Limonoids from Trichilia havanensis
53. Limonoids from Trichilia elegans ssp.
54. Structures of a new limonoid and a new triterpenoid derivative from pericarps of Trichilia connaroides
55. Prieurianoside, a protolimonoid glucoside from the leaves of Trichilia prieuriana
56. Trichavesin, a prieurianin derivative from Trichilia havanensis
57. A new structural proposal for the tetranortriterpenoid dregeanin
58. Recent studies on bioactive compounds from plants
59. Isolation and structures of three secolimonoids, insect antifeedants from Trichilia roka (Meliaceae)
60. Structure of a limonoid antifeedant from Trichilia roka
61. Potent new cell adhesion inhibitory compounds from the root of Trichilia rubra
62. Limonoids showing selective toxicity to DNA repair-deficient yeast and other constituents of Trichilia emetica
63. Antimicrobial activity of Trichilia heudelotti leaves
64. Increased functional cell surface expression of CFTR and DeltaF508-CFTR by the anthracycline doxorubicin
65. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis